## Abstract Multiple studies have documented an increased risk of secondary malignancies in patients receiving alkylating agents. Secondary leukemia following chemotherapy accounts for about 20% of all secondary neoplasms; most are acute nonlymphocytic. Secondary acute lymphoblastic leukemia has ra
Protein study of T and B acute lymphoblastic leukemia cell lines
β Scribed by Dr. Ramzi M. Mohammad; Kerry Vistisen; Ayad Al-Katib
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 629 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0173-0835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract This case represents an example of an unusual Tβcell lymphoblastic leukemia/lymphoma syndrome associated with eosinophilia and myeloid malignancy in a young boy. This case is one of only five reported βleukemicβ variants of the disease and demonstrates the importance of considering this
## Abstract Tβcell acute lymphoblastic leukemia (TβALL) is the result of multiple oncogenic insults of thymocytes. Recently, new __ABL1__ fusion genes have been identified that provide proliferation and survival advantage to lymphoblasts. These are the __NUP214βABL1__ fusion gene, on amplified epis
The relationship between karyotype and expression of the T-cell receptor (TCR) proteins was examined in I9 patients with T-lineage acute lymphoblastic leukemia (T-ALL). All patients expressed CD3 molecules in the cytoplasm or on the cell membrane. Patients were classified according t o TCR expressio